Entities and Variables Related to Catch-up Growth
Launched by ASST FATEBENEFRATELLI SACCO · Apr 10, 2024
Trial Information
Current as of July 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children with celiac disease can experience "catch-up growth," which means growing at a normal rate after being on a gluten-free diet. Researchers want to understand what factors might help these children grow better over a ten-year period. The study will look at information from the medical records of around 900 children who were diagnosed with celiac disease at the V. Buzzi Children’s Hospital in Milan between January 2010 and December 2020.
To be eligible for this study, children must have a confirmed diagnosis of celiac disease according to specific guidelines. However, those with unclear test results, other chronic illnesses, or certain immune system issues will not be included. Participants will not need to do anything special; researchers will use existing medical records to gather the necessary information. This study is currently looking for participants and aims to improve our understanding of how children with celiac disease can grow healthier.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • celiac disease diagnosis established at the V. Buzzi Children\'s Hospital in Milan between January 2010 and December 2020, excluding the extremes, in accordance with the ESPGHAN 2012 or 2020 recommendations.
- Exclusion Criteria:
- • patients with unclear or non-specific duodenal histological alterations (e.g., atrophy with unavailable or negative specific antibodies for celiac disease);
- • patients with additional chronic illnesses;
- • absence of the data required for the study;
- • patients with IgA deficiency, defined as IgA \<20 mg/dl in children \<3 years old or with levels that are below normal for their age.
About Asst Fatebenefratelli Sacco
Asst Fatebenefratelli Sacco is a prominent healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a strong commitment to ethical standards and patient safety, the organization collaborates with leading researchers and healthcare professionals to explore new therapies and treatment options across various medical fields. Asst Fatebenefratelli Sacco leverages its extensive expertise and state-of-the-art facilities to contribute to the global body of medical knowledge, ultimately aiming to enhance the quality of care for patients both locally and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milan, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported